• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从基于 mRNA-LNP 的疫苗在人体中的免疫时间来确定其显著性。

Determination of significant immunological timescales from mRNA-LNP-based vaccines in humans.

机构信息

Department of Mathematics and Statistics, York University, 4700 Keele Street, Toronto, ON, M3J1P3, Canada.

出版信息

J Math Biol. 2023 Apr 30;86(5):86. doi: 10.1007/s00285-023-01919-3.

DOI:10.1007/s00285-023-01919-3
PMID:37121986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10149047/
Abstract

A compartment model for an in-host liquid nanoparticle delivered mRNA vaccine is presented. Through non-dimensionalisation, five timescales are identified that dictate the lifetime of the vaccine in-host: decay of interferon gamma, antibody priming, autocatalytic growth, antibody peak and decay, and interleukin cessation. Through asymptotic analysis we are able to obtain semi-analytical solutions in each of the time regimes which allows us to predict maximal concentrations and better understand parameter dependence in the model. We compare our model to 22 data sets for the BNT162b2 and mRNA-1273 mRNA vaccines demonstrating good agreement. Using our analysis, we estimate the values for each of the five timescales in each data set and predict maximal concentrations of plasma B-cells, antibody, and interleukin. Through our comparison, we do not observe any discernible differences between vaccine candidates and sex. However, we do identify an age dependence, specifically that vaccine activation takes longer and that peak antibody occurs sooner in patients aged 55 and greater.

摘要

提出了一种用于宿主内液体纳米颗粒递送 mRNA 疫苗的隔间模型。通过无量纲化,确定了决定疫苗在宿主内存活时间的五个时间尺度:干扰素 γ 的衰减、抗体的初始、自催化生长、抗体峰值和衰减以及白细胞介素的停止。通过渐近分析,我们能够在每个时间域中获得半解析解,这使我们能够预测最大浓度并更好地理解模型中的参数依赖性。我们将我们的模型与针对 BNT162b2 和 mRNA-1273 mRNA 疫苗的 22 个数据集进行了比较,证明了良好的一致性。使用我们的分析,我们估计了每个数据集的五个时间尺度中的每个时间尺度的值,并预测了血浆 B 细胞、抗体和白细胞介素的最大浓度。通过我们的比较,我们没有观察到候选疫苗和性别的任何明显差异。然而,我们确实发现了年龄依赖性,具体来说,在 55 岁及以上的患者中,疫苗激活需要更长的时间,并且抗体峰值出现得更早。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88f7/10149047/479b89f4332c/285_2023_1919_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88f7/10149047/0ef350faef56/285_2023_1919_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88f7/10149047/a3efd0219111/285_2023_1919_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88f7/10149047/d216db0b2e5c/285_2023_1919_Fig3a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88f7/10149047/5956c6d072b5/285_2023_1919_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88f7/10149047/479b89f4332c/285_2023_1919_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88f7/10149047/0ef350faef56/285_2023_1919_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88f7/10149047/a3efd0219111/285_2023_1919_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88f7/10149047/d216db0b2e5c/285_2023_1919_Fig3a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88f7/10149047/5956c6d072b5/285_2023_1919_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88f7/10149047/479b89f4332c/285_2023_1919_Fig5_HTML.jpg

相似文献

1
Determination of significant immunological timescales from mRNA-LNP-based vaccines in humans.从基于 mRNA-LNP 的疫苗在人体中的免疫时间来确定其显著性。
J Math Biol. 2023 Apr 30;86(5):86. doi: 10.1007/s00285-023-01919-3.
2
Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines.BNT162b2 和 mRNA-1273 两种 SARS-CoV-2 疫苗接种后的 IgG 抗体反应差异。
Microbiol Spectr. 2021 Dec 22;9(3):e0116221. doi: 10.1128/Spectrum.01162-21. Epub 2021 Nov 10.
3
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation.基于核苷修饰的 mRNA 的流感疫苗规避了与 H3N2 疫苗株在鸡蛋中适应相关的问题。
J Virol. 2023 Jan 31;97(1):e0172322. doi: 10.1128/jvi.01723-22. Epub 2022 Dec 19.
4
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.真实世界中衰弱老年人接受延长间隔和异源 COVID-19 mRNA 疫苗接种后的血清学反应(UNCoVER):一项前瞻性观察队列研究的中期报告。
Lancet Healthy Longev. 2022 Mar;3(3):e166-e175. doi: 10.1016/S2666-7568(22)00012-5. Epub 2022 Feb 23.
5
Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination.辉瑞-BioNTech 新冠疫苗接种 6 个月后针对 SARS-CoV-2 关注变异株的抗体反应
Microbiol Spectr. 2022 Apr 27;10(2):e0225221. doi: 10.1128/spectrum.02252-21. Epub 2022 Mar 9.
6
Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine.评估 2 至 3 剂 BNT162b2 mRNA COVID-19 疫苗后针对 SARS-CoV-2 变异株的中和抗体反应。
JAMA Netw Open. 2022 May 2;5(5):e2210780. doi: 10.1001/jamanetworkopen.2022.10780.
7
Comparison of antibody immune responses between BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in naïve and previously infected individuals.比较 BNT162b2 和 mRNA-1273 两种 SARS-CoV-2 疫苗在初免和既往感染个体中的抗体免疫应答。
J Travel Med. 2021 Dec 29;28(8). doi: 10.1093/jtm/taab190.
8
Strength and durability of antibody responses to BNT162b2 and CoronaVac.辉瑞-BioNTech 疫苗和科兴疫苗的抗体反应的强度和持久性。
Vaccine. 2022 Jul 30;40(32):4312-4317. doi: 10.1016/j.vaccine.2022.05.033. Epub 2022 Jun 11.
9
Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.mRNA COVID-19 疫苗类型和免疫调节治疗影响炎症性风湿病患者的体液免疫原性。
Front Immunol. 2022 Oct 13;13:1016927. doi: 10.3389/fimmu.2022.1016927. eCollection 2022.
10
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial.预充间隔对同源和异源 COVID-19 疫苗接种方案的反应原性、免疫反应峰值和消退的影响:Com-COV 的探索性分析,一项随机对照试验。
Lancet Respir Med. 2022 Nov;10(11):1049-1060. doi: 10.1016/S2213-2600(22)00163-1. Epub 2022 Jun 9.

引用本文的文献

1
SARS-CoV-2 booster vaccine dose significantly extends humoral immune response half-life beyond the primary series.SARS-CoV-2 加强疫苗接种剂量可显著延长体液免疫应答半衰期,超过初级系列。
Sci Rep. 2024 Apr 18;14(1):8426. doi: 10.1038/s41598-024-58811-3.
2
Within-host evolution of SARS-CoV-2: how often are mutations transmitted from symptomatic infections?严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的宿主内进化:有症状感染中产生的突变传播频率如何?
Virus Evol. 2024 Feb 21;10(1):veae006. doi: 10.1093/ve/veae006. eCollection 2024.
3
Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV.
新型冠状病毒肺炎疫苗的免疫原性及其对老年艾滋病毒感染者体内艾滋病毒储存库的影响。
iScience. 2023 Sep 14;26(10):107915. doi: 10.1016/j.isci.2023.107915. eCollection 2023 Oct 20.
4
Immunogenicity of COVID-19 vaccines and their effect on the HIV reservoir in older people with HIV.2019冠状病毒病疫苗的免疫原性及其对老年HIV感染者体内HIV储存库的影响。
bioRxiv. 2023 Jun 15:2023.06.14.544834. doi: 10.1101/2023.06.14.544834.
5
Monkeypox: a review of epidemiological modelling studies and how modelling has led to mechanistic insight.猴痘:对流行病学建模研究的回顾,以及建模如何导致对机制的深入了解。
Epidemiol Infect. 2023 May 23;151:e121. doi: 10.1017/S0950268823000791.
6
Multiple cohort study of hospitalized SARS-CoV-2 in-host infection dynamics: Parameter estimates, identifiability, sensitivity and the eclipse phase profile.多队列研究住院 SARS-CoV-2 宿主内感染动力学:参数估计、可识别性、敏感性和隐伏期特征。
J Theor Biol. 2023 May 7;564:111449. doi: 10.1016/j.jtbi.2023.111449. Epub 2023 Mar 7.
7
A mathematical model of protein subunits COVID-19 vaccines.COVID-19 疫苗的蛋白质亚基数学模型。
Math Biosci. 2023 Apr;358:108970. doi: 10.1016/j.mbs.2023.108970. Epub 2023 Feb 10.
8
Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex.基于剂量、年龄和性别,评估 BNT162b2 和 mRNA-1273 疫苗对免疫应答的长期持久性。
Sci Rep. 2022 Dec 8;12(1):21232. doi: 10.1038/s41598-022-25134-0.